Thursday, 30 March 2017

Veterinary Laboratory Testing Services Market Set to Expand by 2024

Veterinary Laboratory Testing Services Market: Overview
Veterinary laboratory testing is referred as the test that is performed for the detection of disease in an animal. The veterinary clinical laboratory industry looks similar to human counterparts. Nearly all the modern clinical laboratory instrument and technologies are widely utilized in the veterinary laboratory marketplace. Compared to human laboratory testing the veterinary laboratory testing market is very daunting. Service level in veterinary laboratory testing market is more challenging as compared to human laboratory industry. Veterinarians are rarely asked to routine laboratory examination for the animals. When veterinarians refer a specimen to a laboratory it signifies that the treated animal is in a critical condition or in a life threatening situation.
Veterinary Laboratory Testing Services Market: Segmentation
The global market for veterinary laboratory testing can be segmented as:
By Method Types
  • ELISA/cELISA
  • Lateral flow tests
  • IFA/IFAT
  • Complement fixation
  • Agglutination
  • Tuberculosis testing
  • Western blot
  • Molecular tests
  • PCR/qPCR
  • Microarrays/Biochips
  • Blots
  • Clinical chemistry
  • Hematology
  • Assay validation
Assay validation and reference range establishment is a very challenging task in human clinical laboratory while the same task can be done easily in veterinary laboratory. Most of the modern instruments used in clinical laboratories are readily utilized in veterinary laboratories in recent times.
Veterinary Laboratory Testing Services Market: Trends and Drivers
Globally, daily disposable income of an individual is increasing rapidly. Thus, the adoption rate of dogs and cats is increasing significantly with increasing disposable income of the global population. Likewise, with increasing adoption rate of dogs and cats the global market for veterinary laboratory testing will also increase. Moreover, prevalence of zoonotic diseases is on the rise among global population. Thus, it is necessary to perform routine examination laboratory test for pet animals.
Moreover, with the rising prevalence of zoonotic diseases the global market for veterinary laboratory testing services will also increase. The cost is very high for veterinary diagnostic product and services is a factor that would restrict the global market demand of veterinary diagnostic testing services market to some extent. Moreover, lack of awareness about veterinary laboratory testing in few of the developing nations is also a factor that might restrict its demand in the global veterinary laboratory testing services market.
Veterinary Laboratory Testing Services Market: Regional Overview
Geographically, North America dominates the global market for veterinary laboratory testing services due to increasing demand for laboratory based diagnostic test for animals. Moreover, increasing awareness among people about laboratory based diagnostic for pet animals will also accentuate the market in North American region.
Europe represents the second position in the global market due to technological advancement and increasing awareness among people. Asia–Pacific is considered as an emerging market in the global veterinary laboratory testing services market due to large number of animals (cow, buffalo and goat) suffering from various diseases.
Fill the form for an exclusive sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=11534
Moreover, the market for veterinary laboratory testing services is at its initial stage in Asian countries. Thus, it is expected that Asia–Pacific will contribute a significant market share during the forecast period. Rest of the World (RoW) region is considered as an untapped market in the global veterinary laboratory testing services market.
Veterinary Laboratory Testing Services Market: Key Players
Major market players contributing the global market share of veterinary laboratory testing services include Heska Corporation, Life Technologies Corporation, Pfizer Animal Health, IDEXX Laboratories Inc., Prionics AG, Abaxis Corporation and Other Market Participants.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
Posted by at No comments:
Labels:

Institutional Pharmacies Market: Applications and Global Markets

Institutional Pharmacies Market: Overview

Pharmacies, or pharmaceutical shop is a kind of shop which is engaged in the selling and distribution of pharmaceutical and healthcare related products (drugs, devices and others) and services (dosing training, medical advice, information about side effects and precautions) to the patients and customers. Pharmacy shop is an inseparable aspect of pharmaceutical sciences field and is one of the most growing field in the healthcare industry.

Pharmacies are broadly classified on the basis of sales nature and end customers, namely, retail pharmacy and institutional (consultant) pharmacy. Retail pharmacies comprises traditional, independent pharmaceutical shops, which are engaged in satisfying the customer needs and interaction with routine customers, whereas, institutional pharmacies offer more emphasis on provision of long-term care facilities, products and services, and on maintenance of patient data and medication history and records.

Although, the institutional pharmacies were not directly involved in patient interaction, due to rising geriatric population and changes in the pharmacy practices, institutional pharmacies have started consulting and guiding the patients directly. Sometimes, institutional pharmacies are considered similar to hospital pharmacies, but former is different on the basis of principles of operating the business and end users.


Institutional Pharmacies Market: Drivers and Trends

The market of institutional pharmacies is expected to grow steadily in upcoming period, owing to various market drivers, such as, benefits of bulk purchase, increased need of institutional pharmacies, rise in geriatric population where patient data monitoring has became essential. In addition, rising prevalence of chronic disease propelling the needs of long-term care, large employment opportunities and rising awareness amongst the pharmaceutical graduates and hospitals regarding the benefits of institutional pharmacies against the traditional pharmacies. Rising geriatric population and chronic disease prevalence are some of the most important drivers of this market.

According to Center for Disease Control and Prevention (CDC), by the 2050, the aged population in the U.S. would exceed 89 million, twice of the 2013. Institutional pharmacies play an important role in maintaining the clinical database and guiding the geriatric patients regarding medications and its associated issues.

Further, increased prevalence of chronic disease is another growth propeller of the institutional pharmacies. According to International Diabetes Federation, 382 million people across the globe are suffering from diabetes, by 2013, and this number is expected to grow to 592 million by the end of 2035.

Institutional Pharmacies Market: Restraints

Fill the form for an exclusive sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=11522

The institutional pharmacies play a vital role in the maintenance of patient medication database related to such chronic diseases and helps in the estimation of further treatments. On the other hand, lack of awareness, high initial costs and stringent government regulations are the major hurdles, expected to impose a threat to the market growth. In addition to this, shrinking medical reimbursement and increasing consolidation of the industry are additional threats to the market growth. The major opportunities include government programmes and campaigns for the promotion of this concept in the world, regulation of laws and rules related to institutional pharmacies would enhance the institutional pharmacies across the globe.

Institutional Pharmacies Market: Key Players

Major players operating in this market include OmniCare, PharMerica, BGS Pharmacy Partners, Golden Horizons, NuScriptRx, Uvanta, Chem Rx Corporation and others. Due to extensive trend of consolidation of the industry, many major players are employing the strategies of acquisitions and partnerships to expand their product portfolio and geographic presence. For instance, Chem Rx Corporation formed partnership with PharMerica to expand the business in New Jersey and New York, U.S. Similarly, BGS Pharmacy Partners acquired Spectrum Pharmacy Services, LLC, to expand the business in Las Vegas, U.S.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453

Posted by at No comments:
Labels:

Real-Time E-Healthcare System Market 2016-2024 Industry Size, Shares and Research Trends

Global Real-Time E-Healthcare System Market: Overview
Even as the healthcare sector undergoes a transformative change from paper-based to digital healthcare records, TMR predicts greater change in this space with the advent of real-time e-healthcare systems. Both patients and healthcare providers are feeling the need to have access to healthcare records in real time. This has led software developers and IT solutions providers to respond via the development of real-time healthcare records and systems.
Simply stated, a real-time e-healthcare system is a digital health platform that allows instant access to healthcare records at any time and from any location. This enables constant communication between medical practitioners and their patients. Health conditions can be monitored more closely and efficiently. The latest generation of real-time e-healthcare systems has gone a step further by allowing patients to check their healthcare records against pre-set parameters to reduce dependence on a third party when doing so.
The unmatched degree of user friendliness afforded by real-time e-healthcare systems will thus prove to be the greatest driver for this market. This will help the market register a very healthy rate of growth, states the report.
Global Real-Time E-Healthcare System Market: Developments, Drivers, and Restraints
The market already features software products such as AccuMed, iPatientCare EHR, e-MDs Chart, and WEBeDoctor that interact with patients for functions ranging from reminding them to take their prescribed medication to notify patients about changes in their health parameters. Since human doctors cannot possibly work so closely with their individual patients, real-time e-healthcare systems are fast filling a void that has existed in the healthcare sector. Community health centers in the U.S. are already experiencing the benefits of deploying real-time e-healthcare systems to improve the quality of healthcare extended to patients.
However, as profitable as this space is turning out to be, it is not without its share of risks. Data breach and computational errors are two grave concerns that companies in the real-time e-healthcare system market need to work around. Moreover, the high cost of maintaining and upgrading such systems could work against their popularity.
Despite these concerns, consumers are expected to have a positive opinion of real-time e-healthcare systems, attracted to their convenience. The growing consumer spending on healthcare facilities, a spiraling use of mobile devices, the demand for home healthcare, and the increasing adoption of integrated healthcare systems on the whole are expected to prove advantageous to this market’s growth. With their initial bugs fixed, real-time e-healthcare systems now make negligible errors and their improve reliability with inspire confidence among consumers.
Global Real-Time E-Healthcare System Market: Important Segments
Fill the form for an exclusive sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=11399
The report segments the global e-healthcare systems market basis product type, geography, and end user. The types of products via which real-time e-healthcare systems can be accessed by or connected to consumers include: mHealth applications, fitness bands, thermometers, blood glucose monitors, and clip-on monitoring devices. Geographically, the key segments of this market are: North America, Asia Pacific, Europe, and Rest of the World. Of these, North America currently represents the largest market for real-time e-healthcare systems. However, Asia Pacific is showing great potential as a profitable market for such systems; the region is expected to register a remarkable rate of growth.
Similarly, by end-user, the market can be segmented into: Individual users, pharmacies, hospitals (public or private).
The market is emerging as an intense competing ground for companies in the healthcare IT industry. Larger companies are acquiring start-ups and niche market players to strengthen specific areas in their portfolios. The companies that currently boast a stronghold in the market are: Medtronic, Fitbit, Jawbone, Garmin, DexCom, Misfit Wearables, GE Healthcare, and Cerner Corporation.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
Posted by at No comments:
Labels:

Global Report on Oxytocic Pharmaceuticals Market

Global Oxytocic Pharmaceuticals Market: Overview
Dubbed the “love hormone,” oxytocin is a female reproductive hormone, produced in the hypothalamus and released into bloodstream during childbirth. This hormone induces labor and milk production in a lactating mother. Oxytocic drugs can be used as uterotonic for induced labor and to reduce the chances of hemorrhage post C-section. Besides this, oxytocic drugs are also administered in conditions such as post-mature birth; uterine atony; pre-eclampsia, which means hypertension during pregnancy; stillbirth; postpartum hemorrhage; and as an adjunct therapy for treatment of autism and in cases of incomplete abortion.
Apart from being administered to humans, oxytocic drugs are also used as veterinary medications. Oxytocin demonstrates its effect after delivery, during childbirth, and toward the end stage of pregnancy.
According to the World Health Organization, every year more than 15 million babies are born prematurely, and this number of preterm births is expected to increase in the coming years. As per the findings of the National Center for Health Statistics, the U.S. alone exhibited a 23.3% labor induction rate in 2012. Considering these statistics, the demand for oxytocic drugs is expected increase significantly in the near future.
The report provides a comprehensive overview of the global oxytocic pharmaceuticals market. It presents insights into the factors influencing the market’s trajectory. The impact of the prevailing demand and supply trends on the market operations is also examined in the report in detail.
Global Oxytocic Pharmaceuticals Market: Key Opportunities and Threats
The increasing incidence of preterm births and the rising rates of labor induction are the primary factors fuelling demand from the global oxytocic pharmaceuticals market. The rising cases of pregnancy-related complications emerging in developing nations also translate into the increased use of oxytocic drugs. Additionally, the market is also expected to gain from the expansion of the health care and pharmaceutical industries in developing countries. However, awareness regarding the side effects related to oxytocic drugs can hamper their use to an extent, thereby restraining the global oxytocic pharmaceuticals market.
Leading brands offer numerous oxytocic products. Pitocin, Octocin, Evatocin, Syntocinon, Pitogin, Duratocin, Cytotec, and Tiacinon are the most popular brands competing for a larger share of the global oxytocic market. However, the synthetic oxytocin derivatives segment is poised to hold the largest share in the market owing to its easy availability. Likewise, hospitals are expected to emerge as the major end-use sector in the market.
Global Oxytocic Pharmaceuticals Market: Region-wise Outlook
Regionally, North America has been exhibiting the highest demand for oxytocic pharmaceuticals due to the high prevalence of induced labor in the region. Europe is expected to emerge as the second-largest market for oxytocic pharmaceuticals due to the rise in oxytocin administration in response to the increasing number of elective caesareans. The market is also anticipated to gain from the increasing case of C-sections in countries in Asia Pacific, such as India and China.
Fill the form for an exclusive sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=11342
Global Oxytocic Pharmaceuticals Market: Vendor Landscape
To study the prevailing competitive landscape of the market, the report profiles companies such as APP Pharmaceuticals, LLC, LBS Labs, Baxter Healthcare Corporation, JHP Pharmaceuticals, LLC, and Pfizer Inc. The report studies these companies based on their business strategies, financial overview, and product portfolio. The strengths and weaknesses of these enterprises are analyzed. The report also presents in-depth overview of the threats and opportunities that these companies are expected to face during the forecast period.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
Posted by at No comments:
Labels:

Wednesday, 29 March 2017

Patient Transport System Market: Industry Overview and Key Factors

Patient transport system enables and ensures on time delivery of medically ill, injured patients to health care organizations/institutions. Patient transport systems with significant resources and experienced staff have become an important and integral part of the health care sector. These systems are required by both critically ill, acute, chronic and non-urgent, planned patients for transport to and from hospitals, rehabilitation centers, clinics, nursing homes, and patient’s home. A patient transport system can be classified into two categories: emergency patient transport system and non-emergency patient transport system. The patient transport system market has experienced significant growth in the past few years and is expected to grow at a higher rate driven by increasing emphasis on improving value chain in the health care sector.
The global patient transport system market has been segmented into emergency patient transport system and non-emergency patient transport system. Emergency patient transport system has been further segmented into ground ambulance services, air ambulance services, and water ambulance services. Based on equipment required during transportation, nature of injury and illness, the patient transport system market has been classified into advanced critical life support ambulance, basic life support ambulance, neonatal ambulance, cardiac ambulance, mobile dialysis ambulance, mobile delivery vans, mobile operation theatres, and air ambulances. Non-emergency transport system provides trips to and from scheduled medical appointments, interdepartmental transfers, and transfers between hospitals. It includes basic life support ambulances, wheelchairs, stretchers, first responder services (two wheelers), mobile beds, etc. In developed countries such as the U.S. and countries in Europe air ambulance, advanced critical life support ambulance, neonatal ambulance, and cardiac ambulance will grow at higher rates as compared to other segments.
Advancement of technology in patient transport system, high demand for safety features, increasing pressure for shortest call response time, and increasing number of cardiac, neonatal, and road accident patients are expected to drive the global patient transport system market. Demand for specialty ambulances for neonatal, cardiac, and gynecology patients is expected to be the key driver of the global patients transport system market. Air ambulance system plays a crucial role in minimizing time for transportation especially from remote locations. Government policies on meeting quicker health care facilities especially in remote areas are also anticipated to contribute to the growth of the global patient transport system market. Increasing number of chronic patients globally, growing emphasis on safety and quality features, upcoming technology with ease of access and improved comfort level, and government policies and regulations in non-emergency medical transport have triggered the growth of the non-emergency patient transport segment. Rising cost of technology and safety standards in non-emergency patient transfer especially in developing countries are the key restraints of the segment.
Fill the form for an exclusive sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=19217
Geographically, the global patient transport system market has been segmented into five regions: North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. North America and Europe are the major markets for patient transport system owing to high expenditure on health care services and advancement of technologies. According to Wall Street Journal blog, countries such as the U.S., China, and Australia were able to transport 75% of seriously injured road accident patients to hospital, whereas this rate was only 10% to 49% in India, Japan, and Pakistan. This blog highlights the scope and opportunity for the growth of patient transport system in Asia Pacific, the Middle East, and Africa. The market in Asia Pacific is expected witness the highest growth rate due to increasing number of road accidents, rising number of patients, incremental growth in the health care sector, and growing pressure to shorten the call response time.
Key players providing patient transport systems are National Medtrans Network, Falck A/S, Air Methods Corporation, Envision Healthcare Corporation, Acadian, NSL Limited, Airmed International LLC, and Airpal, Inc. Falck A/S dominated the emergency patient transport market with expansion plan in Asia Pacific, while NSL Limited is largest private non-emergency ambulance service provider in the U.K.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
Posted by at No comments:
Labels:

Bone Cancer Market is Expected to Witness Highest Growth During 2016 - 2024

One of the most fatal and chronic disorder now a day is Cancer. It is a highly hazardous disease with an extremely high mortality rate due to its highly invasive nature and prolonged duration of disease. Bone cancer is one the types of cancer in which the tissues of bone start growing in uncontrollable manner. This growth can be benign or malignant. In most of the cases, the bone cancer is a result from other cancers.
The major and primary symptom of the bone cancer is severe and intolerable bone pain. This pain increases over the period of time. In addition to pain, symptoms like weight loss, fatigue, bone crack, fever, muscle pain, osteoporosis, and osteopenia are also identified. The diagnostic tests may preliminary include deep study of patient’s history and reasons of pain. Afterwards, the diagnosis of the bone cancer is carried out by using some imaging studies, such as, CT scan, MRI, bone scanning, and PET scanning. Biopsy test is also used for the diagnosis and confirmation of the disease.
Bone cancer market: Segmentation
The market of bone cancer is segmented on the basis of types of bone cancer, such as, primary bone cancer and secondary bone cancer. Primary bone cancer is the type of cancer that originates from rapid and uncontrollable growth of the bone and related tissues. Whereas, secondary cancer is a type of bone cancer, in which, the cancer is originated to some other site of the body and metastasize to the bone structure. The bone cancer is also classified as, osteosarcoma, Ewing’s sarcoma, chondrosarcoma, chordomas, fibrosarcoma, and admantinomas.
Bone cancer market: Types of therapies
the market is also segmented on the basis of therapies and treatments available, such as radiation therapy, chemotherapy, cryosurgery and surgical treatments. Limb amputation surgery, limb salvage surgery or limb sparing surgery are the major surgical practices used to treat bone cancer. Whereas, in radiation therapy, high energy X-rays or gamma-rays are used to destroy the tumors. Chemotherapy is a pharmacological treatment by using anti-cancer drugs either orally or parenterally. Major drugs include strontium-89 chloride, bisphosphonates, methotrexate, denosumab, doxorubicin and many others. Cryosurgery is also sometimes used to treat the bone cancer. In addition, the market is segmented on the basis of geography, such as North America, Europe, Asia-Pacific and Rest of the World (RoW). The North American region is the most dominating market in the world, owing to rapidly growing incidences of bone cancers and rising focus towards R&D for bone tumor treatments. On the other hand, Asia-Pacific and RoW regions are the most promising markets in the upcoming period, owing to rise in awareness of bone cancer, its chronic impacts and its treatments.
Fill the form for an exclusive sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14948
Bone cancer market growth
Although it accounts for much less than one percent of all cancers, the market of bone cancer is expected to grow at a steady rate during the forecast period from 2016 – 2024. This growth is anticipated to be driven by various factors, such as, R&D practices running across the globe, rising awareness amongst the population for bone cancer and other bone diseases, increasing medical infrastructure and technological advancements. Owing to R&D practices, a number of drugs and formulations are under pipeline studies and are expected to enter in the market during forecast period. However, low prevalence of the disease is the major hurdle in the market growth, followed by high cost of R&D, diagnosis and treatment.
According to American Cancer Society estimates, approximately 3,300 new cases of bone cancer are expected to diagnose in 2016, out of which, around 1490 deaths are expected due to bone cancer. Hence, this very low prevalence is the major hurdle in the market growth.
The major players operating in this market include Amgen, Inc., Actavis plc, Novartis International AG, Debiopharm Group, Pfizer, Inc., and Eli Lilly and Company amongst others.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
Posted by at No comments:
Labels:

Separation Systems for Commercial Biotechnology Market is Expected to Rise at a Remarkable CAGR During 2015 - 2023

According to a new market report published by Transparency Market Research “Separation Systems for Commercial Biotechnology Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023”, the separation systems for commercial biotechnology market was valued at US$ 10,665.5 Mn in 2014 and is projected to expand at a CAGR of 6.8% from 2015 to 2023 to reach US$ 19,227.8 Mn in 2023.
Separation systems enable extraction, separation, and purification of a wide range of products and has wide applications in the biotechnology industry. This report studies the global separation systems for Commercial Biotechnology market based on various parameters such as product type, application, and the major geographic markets. Technological advancements would act as a high impact driver of the market. Separation systems such as flow cytometers, chromatography systems, microarray instruments, and membrane filters are likely to propel the market due to high technological developments.
Chromatography systems have gained widespread popularity with the introduction of novel technologies in chromatographic instruments and consumables. Technological advancements in fluorescent labeling and detection methods have offered significant advantage in data, quality, speed, and user safety for microarray based assays.
Liquid chromatography systems held the majority share of the market in 2014, followed by membrane filters. The others segment (biochips, lab-on-a-chip, etc.) has been identified as the fastest growing segment during the forecast period due to its application in point-of-care diagnostic applications as well as in drug discovery and development.
Based on application, the life sciences research and diagnostics segment accounted for over 42.0% share of the global separation systems for commercial biotechnology market in terms of revenue in 2014. Moreover, the segment is expected to gain market share and emerge as the fastest growing segment during the forecast period. Growth of the proteomics market has consequently driven the equipment and supplies market in life sciences research and diagnostics.
Europe was the largest market for separation systems for commercial biotechnology in 2014, accounting for around 29.3% share. The key factor driving the growth of the Separation systems market in Europe is the consistent efforts of various domiciled organizations for the development of chromatography. On the other hand, Asia Pacific is expected to gain significant market share during the forecast period due to high government support for research and in development of the biotechnology industry.
Fill the form for an exclusive sample of this report : http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2104
Danaher Corporation, Thermo Fisher Scientific, Inc., Waters Corporation, Becton, Dickinson and Company, GE Healthcare, and Merck KGaA are the major players operating in the global separation systems market.
The global separation systems for commercial biotechnology market has been segmented as follows:
Global Separation Systems for Commercial Biotechnology Market, by Product Type
  • Centrifugation Systems
  • Liquid Chromatography
  • Electrophoresis Units
  • Membrane Filters
  • Flow Cytometry
  • DNA Microarray
  • Protein Microarray
  • MACS & FACS Systems
  • Others (biochips, lab-on-a-chip, etc.)
Global Separation Systems for Commercial Biotechnology Market, by End User
  • Life Sciences Research
  • Pharmaceuticals
  • Food & Cosmetics
  • Agriculture
  • Energy
Global Separation Systems for Commercial Biotechnology Market, by Geography
  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Rest of Asia Pacific
  • Rest of the World (RoW)
    • Latin America
    • Middle East & Africa
Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Posted by at No comments:
Labels:
Subscribe to: Posts (Atom)